But for investors willing to look past the next few quarters, Guggenheim Securities analyst John DiFucci argues that Oracle (ORCL) is a rare "decade stock" that's just getting started and is on track ...
Oracle Corporation is rated a Buy after a 40% pullback, with the current valuation reflecting key risks. Learn more about ...
Oracle faces continued downside risk as AI deal optimism fades and market sentiment shifts. Click here to read an analysis of ...
OpenAI is signing huge deals with a handful of companies worth hundreds of billions of dollars. Microsoft and Oracle are ...
The strong analyst sentiment was reflected in the January 12, 2026, analyst update, when Goldman Sachs initiated coverage of ...
Fresh concerns about data-center funding weighed down Oracle’s stock on Wednesday, but the selloff is looking overdone to some on Wall Street. Christine Ji is a reporter covering Big Tech.
Two companies at the center of the artificial-intelligence data center investment boom are parting ways, according to a report from the Financial Times. Oracle and alternative investments firm, Blue ...
Larry Ellison’s Oracle is stumbling into the end of the year with its shares taking a beating. The tech firm’s stock has plummeted 30% so far this quarter, CNBC noted Friday. Only four trading days ...
We recently compiled a list of the 7 Most Promising Gene Editing Stocks According to Analysts. Guardant Health, Inc. is one of the most promising stocks. TheFly reported on December 17 that Mizuho ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback